HKSE - Delayed Quote HKD
MedSci Healthcare Holdings Limited (2415.HK)
1.060
+0.020
+(1.92%)
As of 9:45:23 AM GMT+8. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
349,194
349,194
348,950
297,731
215,854
Cost of Revenue
132,587
132,587
142,629
107,921
98,822
Gross Profit
216,607
216,607
206,321
189,810
117,032
Operating Expense
173,786
173,786
199,893
143,442
85,037
Operating Income
42,821
42,821
6,428
46,368
31,995
Net Non Operating Interest Income Expense
15,095
15,095
10,022
4,574
1,048
Pretax Income
60,450
60,450
-96,292
-147,058
33,173
Tax Provision
5,408
5,408
3,589
3,972
4,259
Net Income Common Stockholders
55,042
55,042
-99,881
-151,030
28,914
Average Dilution Earnings
-12,785
-12,785
--
--
--
Diluted NI Available to Com Stockholders
42,257
42,257
-99,881
-151,030
28,914
Basic EPS
0.11
0.11
-0.16
-0.25
0.05
Diluted EPS
0.08
0.08
-0.16
-0.25
0.05
Basic Average Shares
518,070.865
518,070.865
607,170.950
607,170.950
607,170.950
Diluted Average Shares
518,634.007
518,634.007
607,170.950
607,170.950
607,170.950
Total Expenses
306,373
306,373
342,522
251,363
183,859
Net Income from Continuing & Discontinued Operation
55,042
55,042
-99,881
-151,030
28,914
Normalized Income
61,089.791
61,089.791
-97,980.500
-145,602.250
28,487.782
Interest Income
15,371
15,371
10,379
4,845
1,469
Interest Expense
276
276
357
271
421
Net Interest Income
15,095
15,095
10,022
4,574
1,048
EBIT
60,726
60,726
-95,935
-146,787
33,594
EBITDA
69,076
69,076
-87,557
-138,311
40,699
Reconciled Cost of Revenue
132,587
132,587
142,629
107,921
98,822
Reconciled Depreciation
8,350
8,350
8,378
8,476
7,105
Net Income from Continuing Operation Net Minority Interest
55,042
55,042
-99,881
-151,030
28,914
Total Unusual Items Excluding Goodwill
-6,642
-6,642
-2,534
-7,237
489
Total Unusual Items
-6,642
-6,642
-2,534
-7,237
489
Normalized EBITDA
75,718
75,718
-85,023
-131,074
40,210
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-594.209
-594.209
-633.500
-1,809.250
62.782
12/31/2020 - 4/27/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade